Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $11.98 USD
Change Today -0.215 / -1.76%
Volume 2.2M
NVAX On Other Exchanges
As of 2:58 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gregory M. Glenn M.D.

Senior Vice President of Research and Development, Novavax, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2014


Dr. Gregory M. Glenn, M.D., has been Senior Vice President of Research and Development at Novavax, Inc. since January 2014. Dr. Glenn co-founded Intercell USA, Inc. (also known as Iomai Corporation) and has been its Senior Vice President and Chief Scientific Officer since September 1997. Dr. Glenn served as Senior Vice President of Research and Development at Novavax, Inc. since January 13, 2014. Dr. Glenn served as the Chief Medical Officer and Senior Vice President ...

Read Full Background

Corporate Headquarters*

20 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 240-268-2000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


Whitman College
Oral Roberts University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$389,783

Stock Options*

All Other Compensation$9,920
Exercisable Options510,500
Unexercisable Options374,500
Total Number of Options885,000

Total Compensation*

Total Annual Cash Compensation$564,776
Total Short Term Compensation$389,783
Other Long Term Compensation$9,920
Total Calculated Compensation$1,008,261
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $11.98 USD -0.215


Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
Anthony S. Marucci M.B.A.Founder, Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
Laurence James Neil Cooper Ph.D., M.D.Chief Executive Officer
ZIOPHARM Oncology, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at